Acute RyR2 activation by exchange protein directly activated by cAMP (Epac) reversibly perturbs myocyte Ca 2+ homeostasis, slows myocardial action potential conduction, and exerts pro-arrhythmic effects. Loose patch-clamp studies, preserving in vivo extracellular and intracellular conditions, investigated Na + current in intact cardiomyocytes in murine atrial and ventricular preparations following Epac activation. Depolarising steps to varying test voltages activated typical voltage-dependent Na + currents. Plots of peak current against depolarisation from resting potential gave pretreatment maximum atrial and ventricular currents of −20.23 ± 1.48 (17) and −29.8 ± 2.4 (10) pA/μm 2 (mean ± SEM [n]).
| INTRODUCTION
Cardiac arrhythmias result from disruptions in the normal excitable activity propagating through successive structures in the heart. They arise from altered function in surface membrane ionic channels whose successive activation and inactivation underlies the production and propagation of cardiac action potentials (AP). Sustained arrhythmia may require both triggering events and arrhythmic substrate to maintain the resulting abnormal electrical activity. [1] [2] [3] Arrhythmic substrate arises either from slowed myocardial AP conduction or activation, exemplified by Brugada Syndrome, 4, 5 or altered AP recovery, reflected in altered AP duration and/or refractoriness, exemplified by long QT syndrome. 6 Arrhythmic risk is also associated with dysregulated in- associated with the chronic pro-arrhythmic condition of human catecholaminergic polymorphic ventricular tachycardia (CPVT). 8, 9 Triggering events have also been reported following acute adrenergic activation produced by modifications of RyR2-mediated SR Ca 2+ release 10 and surface Ca 2+ channel properties in wild-type hearts expressing normal RyR2 and calsequestrin-2. 11, 12 More recent studies selectively activated RyR2-Ca 2+ release channels using the phosphokinase A (PKA)-independent exchange protein directly activated by cAMP (Epac) pathway. [13] [14] [15] This increased Ca 2+ spark frequencies in adult rat cardiac myocytes 16 and amplitudes of Ca 2+ -dependent Ca 2+ release after isoproterenol treatment 17 in murine ventricular cardiomyocytes. They also increased the amplitudes and frequencies of spontaneous Ca 2+ release. 18 These changes correlated with increases in triggered activity and ventricular tachycardia (VT) in murine hearts. 18 Fewer studies have explored arrhythmic substrate under conditions of altered Ca 2+ homeostasis. Neither chronic modifications in Ca 2+ homeostasis in RyR2-P2328S models nor acute manipulations of Ca 2+ homeostasis in WT hearts altered AP recovery characteristics as reflected in AP durations (APD), refractory periods (ERP), or the relationships between these. 8, 12, 19 However, murine RyR2-P2328S CPVT cardiac models showed reduced atrial 20 and ventricular conduction velocities in common with Na v 1.5-haploinsufficient Scn5a+/− hearts modelling the Brugada Syndrome. 21 Pharmacological inhibition of RyR2-mediated Ca 2+ release with flecainide partly rescued these effects. [22] [23] [24] [25] Furthermore, selective, acute RyR2 activation through the Epac pathway produced parallel pro-arrhythmic effects. 18 It correspondingly produced decreases in AP conduction velocities that were partially reversed by the RyR2 antagonist dantrolene, with an absence of alterations in AP recovery characteristics. 19 The mechanism for the conduction velocity changes in RyR2-P2328S hearts was identified as the direct action of intracellular Ca 2+ on Na v 1.5 function 20, 21, 26 and/or Na v 1.5 membrane expression. 27 However, the mechanisms by which acute manipulations of intracellular Ca 2+ homeostasis, particularly Epac activation, alter AP conduction have not been investigated. The present experiments assessed Nav1.5 activation, inactivation, and recovery from inactivation following acute rather than chronic manipulations of Ca 2+ homeostasis, and in WT rather than genetically-modified hearts. Figure 1 ) and ventricular ( Figure 2 ) preparations subject to a combined pulse procedure (Panel Aa) designed to explore both activation and inactivation properties of Na + currents. Cells were first held at the resting membrane potential (RMP) for 5 ms from the beginning of the recording period. A prepulse of duration 5 ms to V 0 = (RMP−40) mV was then applied to remove any residual Na + current inactivation and standardise the initial activation state of Na + channels within the patch. Na + current activation properties were then investigated using the initial depolarising test voltage steps made to a voltage varied with the 13 successive sweeps between V 1 = RMP to (RMP + 120) mV in +10 mV increments. These currents, following correction for residual leakage by a P/4 protocol, provided a family of records reflecting the voltage dependence of Na + channel activation (Panels Ab and Ba).
Inward currents are represented as downward, negative deflections.
Records typically began with a consistent small upward deflection in response to the −40 mV prepulse. The subsequent voltage steps to level V 1 yielded a family of inward currents initially increasing with time to a peak value that increased as V 1 was made more positive. This was followed by a decay reflecting channel inactivation whose extent and kinetics was similarly determined by the voltage V 1 .
The subsequent voltage steps in the pulse protocol were used to assess properties of the Na + current inactivation resulting from the voltage step to V 1 . Thus, 5 ms following imposition of the latter step, an additional step was applied to a fixed voltage of V 2 = (RMP + 100) mV that would result in a peak Na + current reflecting the extent of the preceding channel inactivation (Panels Ab and Ca). These illustrate the extent of Na + channel inactivation resulting from the step to voltage V 1 . Only the fraction of channels spared such inactivation would then be activated by the step to the fixed voltage V 2 .
| Currents reflecting Na
The Na + current amplitudes would therefore permit quantification of the voltage dependence of Na + channel inactivation at the voltage V 1 .
Records were obtained before 8-CPT challenge (pretreatment) (Ca), following 8-CPT challenge (Cb), and following challenge by 8-CPT combined with dantrolene (Cc). They were compared with results of transferring pretreatment preparations directly to solutions containing dantrolene alone (Cd) or dantrolene combined with 8-CPT (Ce).
The resulting Na + currents showed typical activation and inactivation time courses, but these decreased in amplitude the more depolarised the voltage V 1 (Ca). Again, 8-CPT markedly decreased Na + current amplitudes at all voltages tested (Cb), and further inclusion of dantrolene restored the Na + currents (Cc). Na + currents following challenge by dantrolene alone (Cd) or dantrolene in combination with 8-CPT (Ce)
were similar in amplitude and waveform as pretreatment records.
Thus, the pulse procedures assessing current inactivation similarly demonstrated that 8-CPT reduced Na + current amplitude and this action was rescued by further addition of dantrolene. V 1 towards the Na + current reversal potential. Table 1 summarizes the results of applying voltage steps of a fixed +80 mV amplitude, employing 12 signal-averaged records, to explore the effect of the different pharmacological agents on such maximum peak current under the different pharmacological conditions. The presence of significant differences in both atrial (F = 3.462, P = .013) and ventricular findings between experimental groups (F = 4.071, P = .006) prompted pairwise testing demonstrating differences between results of exposure to 8-CPT compared to findings from untreated patches in both atrial (P < .04) and ventricular cardiomyocytes (P < .004; α = .05). In contrast, there were no detectable differences (P > .2) of findings obtained with challenge by 8-CPT followed by 8-CPT combined with dantrolene, and dantrolene whether alone, or combined with 8-CPT, when all were compared from data from untreated patches.
| Voltage dependences of atrial Na
These findings from Table 1 T 
| Microelectrode recordings of AP characteristics
Reductions of Na + current of the kind described above have been as- ). There were significant pairwise (dV/dt) max differences in cardiomyocytes studied before, and following 8-CPT challenge (atria: P = .002; ventricles: P = .0002) but not following further addition of dantrolene (atria: P = .75; ventricles: P = .99) or addition of dantrolene alone (atria: P = .96; ventricles: P = .36). Thus, further addition of dantrolene restored Na + current previously reduced by 8-CPT (atria: P = .042; ventricles: P = .0004; Figures 7C and 8C ). The similar findings in both atrial and ventricular preparations thus paralleled corresponding observations in loose patch clamp Na + currents. In contrast, resting membrane potentials showed no significant differences between groups (atria: F = 1.24, P = .30; ventricles: F = 1.18, P = .32), falling close to −75 mV in both atrial and ventricular cardiomyocytes ( Figures 7D and 8D) .
Similarly, action potential durations at 90% recovery showed no significant differences between experimental groups (atria: F = 2.10, P = .11; ventricles: F = 1.24; P = .296), falling close to ~35 and ~60 ms in atrial and ventricular cardiomyocytes respectively ( Figures 7E and   8E ).
| DISCUSSION
The experiments here investigated for acute effects of Epac activation, known to acutely perturb cellular Ca 2+ homeostasis, 18 upon Na increased incidences of both triggered activity and ventricular tachycardia (VT). 18 However, it also (iii) associated such pro-arrhythmic effects with decreased conduction velocities. 19 Furthermore, (iv) these electrophysiological characteristics were rescued by the RyR2-Ca 2+ release channel blocker dantrolene, despite (v) all these changes being associated with unaltered recovery characteristics as reflected in the cardiac action potential (AP) durations and ventricular effective refractory periods. 18, 19 Such findings suggest that acutely altered Ca 2+ homeostasis might result in arrhythmic substrate arising from delayed conduction, as previously suggested for the pro-arrhythmic Brugada syndrome [1] [2] [3] [4] [5] in contrast to the recovery abnormalities associated with the LQT syndromes. sparks in cardiomyocyte models for CPVT 36 and cardiac failure. 37, 38 (iii) Effects of dantrolene were further controlled for in experiments involving direct exposure to dantrolene, both by itself and in combination with 8-CPT (cf. 19 ), and (iv) The experiments similarly measured the time courses and steady-state voltage-dependences of Na + current activation and inactivation (cf. 21 ), in both atrial and ventricular preparations from WT murine hearts.
The variation of the test step to voltage V 1 allowed measurement of the peak amplitudes of Na + current and yielded current-voltage activation relationships. These peaks were followed by decays to a steady-state inactivation level whose dependence upon the voltage The present findings thus implicate conduction velocity secondary to compromised Na + current as a source for arrhythmic substrate under conditions of acutely perturbed cytosolic Ca 2+ homeostasis, reconstructing the altered conduction previously reported in Na v 1.5 haplo-insufficient, Scn5a +/− murine models for Brugada Syndrome. [1] [2] [3] [4] [5] They also complement previous findings in murine hearts chronically modelling catecholaminergic polymorphic ventricular tachycardia (CPVT). Cardiomyocytes in the latter systems similarly showed diastolic episodes, or propagating waves, of RyR2-mediated Ca 2+ release, as well as afterdepolarisation and triggering phenomena. 8, 9 RyR2-P2328S hearts additionally showed parallel reductions in atrial 21 and ventricular action potential conduction velocities, the latter particularly following catcholaminergic challenge. 20 These changes accompanied chronically downregulated Na v 1.5 expression. 21, 27 Furthermore, WT rat cardiomyocytes increased their expression of functionally active surface membrane Na v 1.5, Na v 1.5 mRNA and total Na v 1.5 protein following verapamil 
| MATERIALS AND METHODS

| Solutions
Krebs-Henseleit (KH) solution was prepared (mmol/L: NaCl, 119; was prepared and filtered to remove particles greater than 10 μm in diameter with standard filtration paper (Millipore, Bedford, MA, USA).
| Tissue preparation
This research has been regulated under the Animals (Scientific In the text membrane potentials are therefore stated in terms of their displacement from the RMP in the same convention adopted by earlier studies using this technique. 29, 57 The loose patch clamp configuration results in larger leakage currents than the conventional patch clamp due to the comparatively low seal resistance. A custom-built amplifier was used to compensate for the majority of the leakage current, series resistance errors and the displacement current through the pipette capacitance. 28 Residual leakage and capacitative currents were corrected for using reference records from subsequent P/4 control protocols applying steps whose amplitudes were scaled down by a factor of four and of the opposite sign relative to the test steps, as fully described previously. 29, 57 Experiments were first performed under pretreatment condi- Each patch was subject only to a single application of the pulse protocols. These made differences between results attributable to prolonged changes in the patch such as bleb formation unlikely. 
| Whole heart intracellular microelectrode recordings
Microelectrode studies were performed using a modified horizontal waveform. These were measured along with cardiomyocyte resting potentials, RMP, with AP amplitude measured from the RMP to the peak AP voltage. Action potential duration was measured as the time from the AP peak to 90% repolarisation to baseline.
| Analysis of results
The currents obtained from the loose patch procedure are dimensioned in units of current (nA). Subsequent analysis converted the units of current (nA) to current densities (pA/μm 2 ) using the formula:
Current-voltage curves describing Na + current activation and inactivation and current-time relationships plotting the recovery timecourse of Na + current from inactivation were obtained from the corresponding measurements of peak Na + currents (means ± standard error of the mean [SEM]) in the relevant protocol (see Figure 1Aa ). Peak Na 
| Statistical analysis of results
Owing to the limited recording time permitted following establishment of each loose patch, 58 Current density = 1000 × current (π×pipette radius 2 )
